RHEAVITA BV
RheaVita specializes in innovative continuous freeze-drying technology for biopharmaceutical products, offering scalable solutions from R&D to GMP manufacturing. Their approach enhances efficiency, reduces costs, and guarantees product quality, with a focus on process development, formulation, and production services. They have strategic partnerships and a history rooted in academic and industry collaboration, aiming to revolutionize lyophilization processes.
Industries
Nr. of Employees
small (1-50)
Products
Single-position R&D continuous freeze-dryer (small-scale)
Small-scale continuous freeze-dryer optimized for R&D and formulation development with rapid, small-batch continuous processing.
Multi-position preclinical continuous freeze-dryer
Mid-scale continuous freeze-dryer for pre-clinical production with direct scalability to GMP lines and minimal tech transfer requirements.
GMP-capable flexible continuous freeze-dryer line (high-throughput variants)
GMP-ready continuous freeze-drying line family with robotic automation and multiple capacity variants intended for clinical and commercial production.
Single-position R&D continuous freeze-dryer (small-scale)
Small-scale continuous freeze-dryer optimized for R&D and formulation development with rapid, small-batch continuous processing.
Multi-position preclinical continuous freeze-dryer
Mid-scale continuous freeze-dryer for pre-clinical production with direct scalability to GMP lines and minimal tech transfer requirements.
GMP-capable flexible continuous freeze-dryer line (high-throughput variants)
GMP-ready continuous freeze-drying line family with robotic automation and multiple capacity variants intended for clinical and commercial production.
Services
Experimental evaluation of formulation compatibility and processability on continuous freeze-drying equipment without customer CAPEX.
GMP-compliant production runs for pre-clinical, TOX and stability batches on continuous freeze-drying lines.
Courses on freeze-drying fundamentals and advanced continuous spin-freeze drying technology; customizable training delivered on-site or at provider facilities and regular free webinars.
Pre-engineering projects and consultancy to support implementation of GMP-capable continuous freeze-drying lines and to educate third-party CMOs on the technology.
Experimental evaluation of formulation compatibility and processability on continuous freeze-drying equipment without customer CAPEX.
GMP-compliant production runs for pre-clinical, TOX and stability batches on continuous freeze-drying lines.
Courses on freeze-drying fundamentals and advanced continuous spin-freeze drying technology; customizable training delivered on-site or at provider facilities and regular free webinars.
Pre-engineering projects and consultancy to support implementation of GMP-capable continuous freeze-drying lines and to educate third-party CMOs on the technology.
Expertise Areas
- Continuous lyophilization
- Freeze-drying process development
- Formulation development for vaccines and biologics
- Process analytical technologies (PAT)
Key Technologies
- Spin-freezing (rotational vial freezing)
- Continuous lyophilization
- Infrared radiative heating
- Near-infrared (NIR) spectroscopy (in-line)
News & Updates
RheaVita announces a strategic partnership with IMA Life to drive technological development and growth.
Introduction of new spin-freezing drying technology.
Scientific solutions for persistent pain points in batch freeze-drying.
Announcement of the launch of a BSL-2 compliant laboratory freeze-dryer.
RheaVita becomes a member of lyoHUB.
Discussion on the significance of flexible manufacturing systems.
RheaVita announces a strategic partnership with IMA Life to drive technological development and growth.
Introduction of new spin-freezing drying technology.
Scientific solutions for persistent pain points in batch freeze-drying.
Announcement of the launch of a BSL-2 compliant laboratory freeze-dryer.
RheaVita becomes a member of lyoHUB.
Discussion on the significance of flexible manufacturing systems.